---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-034340"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2026-07-23T12:40:28+00:00"
generated_at: "2026-07-23T12:45:15.843982+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Canton Strategic sells Gravitas Life Sciences for $3.5M note; focuses on Canton Network

## Summary
- Sold 100% of Gravitas Life Sciences to Gravitas Collective Corp. for $3.5M unsecured promissory note (15% interest, matures July 2029) plus milestone payments.
- Buyer affiliated with former directors Vincent LoPriore, Sireesh Appajosyula, Gary Stetz; transaction approved by special committee.
- Company retains bispecific antibodies assets via Tharimmune SPV1; pro forma shows reduced operating losses (Q1 2026 net loss improves from $47.3M to $45.5M).
- Divestiture aligns with transition to operating company driving digitization of financial markets via Canton Network; locking service launched June 2026.

## SEC filing metadata
- accession: 0001493152-26-034340
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2026-07-23T12:40:28+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000149315226034340/0001493152-26-034340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000149315226034340/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-034340
- JSON: https://secwatch.observer/filing/0001493152-26-034340.json
- Plain text: https://secwatch.observer/filing/0001493152-26-034340.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.